Home / Stocks / Medi Caps Ltd.
MEDICAPQ

Medi Caps Ltd. Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹22.94

Change

+0.96 (4.37%)

Open

₹21.5

Prev. Close

₹21.98

Day High

₹23.06

Day Low

₹21.5

Volume Analysis

Traded

1,603

Delivered

1,603

Delivery %

100.0%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Promoter holding is rising

Weaknesses (3)

  • •Low return on equity (-9.21%)
  • •Below-average fundamentals quality score (31/100)
  • •Low operating margin (-28.31%)

Opportunities (0)

No signal for this stock

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹25.06 ₹24.06 ₹23.5 ₹22.5 ₹21.94 ₹20.94 ₹20.38
Fibonacci ₹24.06 ₹23.46 ₹23.1 ₹22.5 ₹21.9 ₹21.54 ₹20.94
Camarilla ₹23.37 ₹23.23 ₹23.08 ₹22.5 ₹22.8 ₹22.65 ₹22.51

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

—

1 Week

+0.0%

1 Month

-8.24%

3 Months

-8.97%

6 Months

—

1 Year

—

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

DuPont ROE Breakdown

-0.04%

Net margin -0.31% × asset turnover 0.11x × equity multiplier 1.03x

Company Overview

Sector

Healthcare

Market Cap

₹33 Cr

ROE

-9.21%

Book Value

₹89.4

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 16 Nov 2026. Not investment advice.

TopFund Analysis

Medi Caps Ltd. scores weakly on TopFund's composite fundamentals check within the Healthcare sector, at 31/100. The strongest factor is Financial Strength (100/100), while Growth (0/100) is the weakest area to weigh before deciding. Notably: Promoter holding is rising; low return on equity (-9.21%); below-average fundamentals quality score (31/100).

TopFund Score — Fundamentals Quality

31/100 — Weak

Data confidence: 72/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

100

Growth

0

Valuation

13

Cash Flow

0

Corporate Governance

66

Momentum

21

Institutional Ownership

30

Business Quality

20

Risk & Volatility

14

Liquidity

50

From Screener.in

  • +Company is almost debt free.
  • +Stock is trading at 0.27 times its book value
  • +Company is expected to give good quarter
  • −Company has low interest coverage ratio.
  • −The company has delivered a poor sales growth of -26.3% over past five years.
  • −Company has a low return on equity of -4.34% over last 3 years.
  • −Earnings include an other income of Rs.6.47 Cr.

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Extract of unaudited standalone and consolidate financial results of the company for the quarter/half year ended 30.09.2026 published in free press English edition and choutha …

Board approved unaudited Q2/H1 FY2026 results on 4 Nov 2026; consolidated loss was Rs 232.12 lakh.

Certificate for Compliance under Reg. 74(5) of SEBI (D.P.) Regulation 2018 for the quarter ended 30.09.2026

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 6 7 8 6 8 4 7 3 2 4 3 3 6
Expenses + 6 6 8 6 8 6 7 6 5 5 6 5 5
Operating Profit 1 1 -1 0 0 -2 0 -3 -3 -1 -2 -2 0
OPM % 8.29% 9.9% -6.35% -4.52% 5.43% -44.28% -3.3% -125.65% -144.06% -24.65% -59.71% -65.59% 5.71%
Other Income + 0 0 0 0 0 0 2 0 2 1 6 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 1 0 0
Profit before tax 0 0 -1 -1 0 -2 1 -4 -2 -1 3 -2 0
Tax % 0.0% 150.0% 83.05% 0.0% 0.0% 0.0% -18.62% 0.0% 0.0% 4.05% -0.33% 0.0% 0.0%
Net Profit + 0 0 -1 -1 0 -2 2 -3 -2 -1 3 -2 0
EPS in Rs 0 0 -1 0 0 -2 1 -3 -1 -1 2 -2 0
Raw PDF — — — — — — — — — — — — —
YoY Sales growth -61 -36 -26 -3 37 -43 -11 -57 -76 7 -51 4 186

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 36 43 44 54 52 43 57 70 49 27 25 12 16
Expenses + 36 40 42 52 47 50 46 60 44 27 27 22 21
Operating Profit 0 3 2 2 5 -7 11 10 5 0 -2 -9 -5
OPM % -0.22% 6.07% 3.66% 4.04% 9.11% -15.68% 19.1% 14.41% 10.51% 0.0% -7.06% -75.58% -28.31%
Other Income + 1 1 2 1 3 3 2 2 1 0 3 8 6
Interest 1 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 2 2 2 2 2 2 2 2 2 2 2 2 2
Profit before tax -1 1 2 1 6 -6 11 10 5 -1 -1 -3 0
Tax % 63.49% 39.16% 20.35% 14.81% 2.18% 0.17% -0.09% 0.1% 63.62% 80.0% -32.14% 0.66% —
Net Profit + -2 1 1 1 5 -6 11 10 2 -2 -1 -3 0
EPS in Rs -2 1 1 1 4 -5 9 8 1 -2 0 -2 0
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% —
Sales growth -4 19 2 22 -4 -17 33 22 -29 -45 -7 -51 4

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 69 70 77 78 83 78 92 104 106 109 109 99 99
Borrowings + 1 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities + 7 11 8 11 11 4 10 14 7 6 4 4 3
Total Liabilities 89 93 97 101 107 95 115 130 126 127 125 115 114
Fixed Assets + 58 56 62 61 60 57 58 59 59 59 57 56 54
CWIP 0 0 0 0 0 1 1 0 0 0 0 0 0
Investments 5 7 8 11 16 22 29 31 32 38 43 35 38
Other Assets + 26 30 27 29 30 15 27 40 35 30 25 24 22
Total Assets 89 93 97 101 107 95 115 130 126 127 125 115 114
Equity Capital 12 12 12 12 12 12 12 12 12 12 12 12 12

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 7 3 4 4 6 5 15 7 -6 7 5 -7
Cash from Investing Activity + -7 -1 3 -4 -6 -6 -10 -4 -3 -8 -5 7
Cash from Financing Activity + 0 -1 -6 0 0 0 0 0 0 0 0 0
Net Cash Flow 0 0 1 0 0 -1 6 3 -9 -1 0 0
Free Cash Flow 7 2 9 4 5 3 13 4 -7 7 5 -8
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit -9,750 120 270 202 128 -69 140 70 -58 — -267 74

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 50.13% → 51.44%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 49.85% 49.84% 49.83% 49.54% 49.35% 49.21% 49.21% 49.19% 49.21% 48.61% 48.54% 48.53%
Promoters 50.13% 50.13% 50.13% 50.42% 50.61% 50.76% 50.76% 50.76% 50.76% 51.36% 51.44% 51.44%
DII 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.02% 0.02% 0.02% 0.02%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Medi Caps Ltd. (this stock) 33 — 0.27 -9.21%
Vivo Bio Tech Ltd. 35 — 0.37 -2.24%
Gkb Ophthalmics Ltd. 31 11.2 0.56 3.28%
Vivimed Labs Limited 43 — -0.2 —
Mangalam Drug & Chem Ltd 45 — 0.51 -35.3%
Ortin Global Limited 11 — — —
Sunil Healthcare Ltd. 78 26.6 1.03 6.01%

Which Mutual Funds Hold Medi Caps Ltd.?

Frequently Asked Questions about Medi Caps Ltd.

Community Sentiment

What are other investors saying about Medi Caps Ltd.?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.